ClinicalTrials.Veeva

Menu

Mumbai Worksite Tobacco Control Study

P

President and Fellows of Harvard College

Status

Completed

Conditions

Tobacco Use Cessation

Treatments

Behavioral: Delayed Intervention
Behavioral: Intervention Program

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT01841879
R01CA140304 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The investigators are designing and testing the effectiveness of an integrated tobacco control and occupational health (OH) intervention aimed at promoting tobacco cessation among workers and supporting the adoption, implementation, and enforcement of tobacco control policies in 20 manufacturing worksites in the greater Mumbai region of India.

Full description

Through 6 health education events at the worksites, blue-collar workers (who face dual health risks through their exposures to occupational hazards and their high rates of tobacco use) will gain the knowledge, skills, and social support needed to quit tobacco use.

Simultaneously, management will receive OH and tobacco policy consultations to help build a healthy and safe work environment, where workers' hazardous exposures are reduced.

Enrollment

6,880 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Manufacturing worksites located in the Mumbai, Thane, or Raigad districts of India
  • Employ at least 60% production workers/40% administrative staff OR at employ at least 200 production workers on staff. NOTE: We are defining "workers" as anyone who is on the company roster, regardless of whether they're permanent or contractual
  • Companies must be autonomous decision-makers and allow us to function at their worksite
  • Companies must be willing to provide us with a current employee roster

Exclusion criteria

  • Employees do not speak English, Hindi, or Marathi

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

6,880 participants in 2 patient groups

Intervention Program
Experimental group
Description:
Receives the full Healthy, Safe, and Tobacco-Free Worksites intervention
Treatment:
Behavioral: Intervention Program
Delayed Intervention Control
Other group
Description:
Receives abbreviated 2-month delayed intervention designed to provide employees with knowledge and skills to quit tobacco after final data collection time point, as well as one non-tobacco event in between data collection points.
Treatment:
Behavioral: Delayed Intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems